Skip to main content
Amanda Redig, MD, Oncology, Boston, MA

Amanda J Redig MD PhD


Brigham and Women's Hospital

Join to View Full Profile
  • 75 Francis StBoston, MA 02115

  • Phone+1 617-732-5500

Dr. Redig is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer Institute
    Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2013 - 2017
  • Mass General Brigham/Brigham and Women's Hospital
    Mass General Brigham/Brigham and Women's HospitalResidency, Internal Medicine, 2010 - 2013
  • Northwestern University The Feinberg School of Medicine
    Northwestern University The Feinberg School of MedicineClass of 2010

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2012 - 2025
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Medical Oncology
    American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Effect of Erlotinib plus Bevacizumab vs Erlotinib Alone on Progression-Free Survival in Patients with Advanced EGFR-Mutant Non-Small Cell Lung Cancer: A Phase 2 Randomized Clinical Trial
    Effect of Erlotinib plus Bevacizumab vs Erlotinib Alone on Progression-Free Survival in Patients with Advanced EGFR-Mutant Non-Small Cell Lung Cancer: A Phase 2 Randomized Clinical TrialAugust 8th, 2019
  • On the Road at ASCO 2023: Key Takeaways, Observations and Reflections
    On the Road at ASCO 2023: Key Takeaways, Observations and ReflectionsJuly 13th, 2023

Grant Support

  • The Protein Kinase C Pathway In Acute LeukemiaNational Institute Of Environmental Health Sciences2007–2009

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: